Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Risk Stratification for Intermediate- and High-Risk Patients

被引：3
|
作者：
Katz, A. [1 ]
Kang, J. [2 ]
机构：
[1] FROS Radiat Oncol & CyberKnife Ctr, Flushing, NY USA
[2] Cornell Univ, Coll Med, New York, NY 10021 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1251
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2608
引用
收藏
页码：E250 / E250
页数：1
相关论文
共 50 条
  • [31] Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer
    Ju, Andrew W.
    Wang, Hongkun
    Oermann, Eric K.
    Sherer, Benjamin A.
    Uhm, Sunghae
    Chen, Viola J.
    Pendharkar, Arjun V.
    Hanscom, Heather N.
    Kim, Joy S.
    Lei, Siyuan
    Suy, Simeng
    Lynch, John H.
    Dritschilo, Anatoly
    Collins, Sean P.
    [J]. RADIATION ONCOLOGY, 2013, 8
  • [32] Pelvic Nodal Dosing With Registration to the Prostate: Implications for High-Risk Prostate Cancer Patients Receiving Stereotactic Body Radiation Therapy
    Kishan, Amar U.
    Lamb, James M.
    Jani, Shyam S.
    Kang, Jung J.
    Steinberg, Michael L.
    King, Christopher R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 91 (04): : 832 - 839
  • [33] Lack of Benefit From the Addition of External Beam Radiation Therapy to Brachytherapy for Intermediate- and High-risk Prostate Cancer
    Yang, David D.
    Muralidhar, Vinayak
    Nguyen, Paul L.
    Buzurovic, Ivan
    Martin, Neil E.
    Mouw, Kent W.
    Devlin, Phillip M.
    Quoc-Dien Trinh
    Orio, Peter F., III
    King, Martin T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (04): : 904 - 911
  • [34] Trends in Androgen Deprivation Therapy Use With Radiation for Intermediate- and High-Risk Prostate Cancer Across the United States
    Falchook, A.
    Mohiuddin, J. J.
    Chen, R. C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S45 - S45
  • [35] Incomplete response to therapy in intermediate- and high-risk thyroid cancer
    Ali S. Alzahrani
    Noha Mukhtar
    [J]. Endocrine, 2022, 78 : 531 - 542
  • [36] Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
    Anwar, Mekhail
    Weinberg, Vivian V.
    Seymour, Zachary
    Hsu, I. Joe
    Roach, Mack, III
    Gottschalk, Alex R.
    [J]. RADIATION ONCOLOGY, 2016, 11
  • [37] Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer
    Mekhail Anwar
    Vivian Weinberg
    Zachary Seymour
    I. Joe Hsu
    Mack Roach
    Alex R. Gottschalk
    [J]. Radiation Oncology, 11
  • [38] Thermal Partial Prostate Ablation for Intermediate- and High-risk Prostate Cancer: Con
    Gaffney, Christopher D.
    Ehdaie, Behfar
    [J]. EUROPEAN UROLOGY FOCUS, 2023, 9 (04): : 660 - 661
  • [39] Phase 1 Trial of Stereotactic Body Radiation Therapy Neoadjuvant to Radical Prostatectomy for Patients With High-Risk Prostate Cancer
    Parikh, Neil R.
    Kishan, Amar U.
    Kane, Nathanael
    Diaz-Perez, Silvia
    Ganapathy, Ekambaram
    Nazarian, Ramin
    Felix, Carol
    Mathis, Colleen
    Bradley, Margaret
    Sachdeva, Ankush
    Wyatt, Bashir
    Basehart, Vince
    Zomorodian, Nazy
    Lin, Lin
    King, Christopher R.
    Kupelian, Patrick A.
    Rettig, Matthew B.
    Steinberg, Michael L.
    Cao, Minsong
    Knudsen, Beatrice S.
    Elashoff, David
    Schaue, Dorthe
    Reiter, Robert E.
    Nickols, Nicholas G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (04): : 930 - 935
  • [40] Incomplete response to therapy in intermediate- and high-risk thyroid cancer
    Alzahrani, Ali S.
    Mukhtar, Noha
    [J]. ENDOCRINE, 2022, 78 (03) : 531 - 542
12345